1. Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United States
- Author
-
Erica Engelberg-Cook, PhD, Jaimin S. Shah, MD, Andre Teixeira da Silva Hucke, MS, Diana V. Vera-Garcia, MD, Jany E. Dagher, Megan H. Donahue, BS, Veronique V. Belzil, MS, PhD, and Björn Oskarsson, MD
- Subjects
Medicine (General) ,R5-920 - Abstract
Objective: To assess the performance of known survival predictors and evaluate their stratification capability in patients with amyotrophic lateral sclerosis (ALS). Patients and Methods: We analyzed demographic and clinical variables collected at the Mayo Clinic, Florida ALS center during the first clinical visit of 1442 (100%) patients with ALS. Results: Our cohort had a median (interquartile range [IQR]) age at diagnosis of 64.8 (57-72) years; 1350 (92%) were non-Hispanic White; and 771 (53.5%) were male. The median (IQR) diagnostic delay was 10.1 (6-18) months, body mass index was 25.4 (23-49), and forced vital capacity was 72% (52%-87%). Approximately 12% of patients tested carried a pathologic C9orf72 hexanucleotide repeat expansion. Median (IQR) ALS functional rating scale-revised score was 35 (29-40) and ALS cognitive behavioral screen score was 15 (12-17). The median (IQR) survival after diagnosis was 17.2 (9-31) months, and survival from symptom onset was 30 (20-48) months. We found that older age decreased forced vital capacity, and fast-progressing ALS functional rating scale-revised scores significantly (P
- Published
- 2024
- Full Text
- View/download PDF